MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about updates

07 Nov 2024 Evaluate
In accordance with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Welcure Drugs & Pharmaceuticals has informed that it enclosed Statement of deviation/variation in utilization of funds as on September 30, 2024.

The above information is a part of company’s filings submitted to BSE.

Peers